Aneel A. Ashrani

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane, Waldemar E. Wysokiński, Jennifer Le‐Rademacher et al. · Journal of Thrombosis and Haemostasis · 2019 · 554 citations

Thrombosis, Venous Thrombosis, Adam Vte Trial +6

Genetic diversity fuels gene discovery for tobacco and alcohol use

Gretchen Saunders, Xingyan Wang, Fang Chen et al. · Nature · 2022 · 470 citations · Full text

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018

Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini et al. · Journal of the National Comprehensive Cancer Network · 2018 · 241 citations · Full text

Cancer Management, Nccn Guidelines Insights, Pathology +16

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015

Michael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani et al. · Journal of the National Comprehensive Cancer Network · 2015 · 216 citations

Version 1.2015, Pathology, Effective Prophylaxis +18

Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study

Cheng E. Chee, Aneel A. Ashrani, Randolph S. Marks et al. · Blood · 2014 · 207 citations